Q32 Bio Inc (QTTB) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Q32 Bio Inc   (NASDAQ: QTTB)


Q32 Bio Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Q32 Bio Inc 's ROA in the third quarter of 2026?
Q32 Bio Inc achieved a return on average assets (ROA) of 23.87 % in its third quarter of 2026, this is above QTTB's average return on assets of -26.29%.
Q32 Bio Inc assets over the 12 months ending in its third quarter of 2026 are valued at $135 million

ROA fell compared to the second quarter of 2026, despite the net income growth of % from the second quarter of 2026.

However, within the Healthcare sector 21 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 66, from total ROA ranking in the second quarter of 2026 at 100.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 410.72 % 72.58 % -19.31 % -34.11 % -44.45 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 32 34 33 30 -42
Return On Assets (TTM) 23.87 % 44.99 % 52.78 % 44.62 % -56.2 %
QTTB's Total Ranking # 66 # 100 # 4126 # 4225 # 4295
Total Assets (TTM) in million 298 115 64 62 58
Seq. Total Assets Change 159 % 79.13 % 3.04 % 6.83 % -12.48 %
Seq. Net Income Change - - - - -

QTTB's 5 Years Annual ROA >> Back to QTTB Management Effectiveness >> Compare QTTB ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 12
Sector # 22
Overall # 75

Return On Assets Statistics
High Average Low
53.33 %
-26.29 %
-61.16 %
(Mar 31 2026)   (Jun 30 2025)





Financial Statements
Q32 Bio Inc 's Assets $ 298 million QTTB's Balance sheet
Q32 Bio Inc 's Income $ -9 million Quarterly QTTB's Income Statement
QTTB's Income by Division See QTTB's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -32.86 % 9.95 % -62.93 % 7.73 % -19.67 %
Total Assets in million 62 93 85 228 212
Y / Y Net Income Change - - - - -
Net Income in million 30 -48 -113 -5 -96
Annual Return On Assets 47.77 % -51.34 % -133.58 % -2.19 % -45.23 %

QTTB's 5 Years Annual ROA >> Back to QTTB Management Effectiveness >> Compare QTTB ROA to its Competitors



Comment on QTTB's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 47.77 % compared to prior year, due to annual net income growth of % to $29.82 million, and due to decline of value in Q32 Bio Inc 's assets by -32.86 % to $62.42 million, compared to $62.42 a year before.


More Return On Assets Ratios
QTTB's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
QTTB's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for QTTB's Competitors
Subscribers only: Roa for Q32 Bio Inc 's Suppliers
Subscribers only: Return On Assets for QTTB's Customers

You may also want to know
QTTB's Roi QTTB's Inventory Turnover Ratio QTTB's Growth Rates QTTB's Dividend Comparisons
QTTB's Profitability Ratios QTTB's Asset Turnover Ratio QTTB's Dividend Growth
QTTB's Roe QTTB's Valuation Ratios QTTB's Financial Strength Ratios QTTB's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Exelixis Inc   63.88 %
Rigel Pharmaceuticals Inc  59.56 %
Alnylam Pharmaceuticals Inc   46.08 %
Ironwood Pharmaceuticals inc   42.53 %
Aurinia Pharmaceuticals Inc   40.63 %
Nurix Therapeutics Inc   38.61 %
Indivior Pharmaceuticals Inc   36.35 %
Rallybio Corporation  34.55 %
Idexx Laboratories Inc  34.05 %
Zevra Therapeutics Inc   26.33 %
Caredx Inc   25.74 %
Medpace Holdings Inc   24.47 %
Acadia Pharmaceuticals Inc   21.60 %
Standard Biotools Inc   21.56 %
Eli Lilly And Company  21.24 %
Iradimed Corporation  20.89 %
Resmed Inc   18.67 %
Alector Inc   18.37 %
Corcept Therapeutics Inc  18.09 %
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %

Date modified: 2026-11-05T10:10:18+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.